top of page

Publications

Selected publications related to current research focus:

​

  1. Halim J, Carr RA, Fliorent R, Jonnalagadda K, Kurbonnazarova M, Kaur M, Millstein I, and Carabetta VJ. Combinations of antibiotics effective against extensively- and pandrug-resistant Acinetobacter baumannii patient isolates. Microorganisms 2024 12(7): 12071353.

  2. Recktenwald M, Kaur M, Benmassaoud MM, Copling A, Khanna T, Curry M, Cortes D, Fleischer G, Carabetta VJ, and Vega SL. Antimicrobial peptide screening for designing custom bactericidal hydrogels. Pharmaceutics 2024 16(7): 16070860. 

  3. Carr RA, Tucker T, Newman PM, Jadalla L, Jaludi K, Reid BE, Alpheaus DN, Korrapati A, and Carabetta VJ. Nε-lysine acetylation of the histone-like protein HBsu influences antibiotic survival and persistence in Bacillus subtilis. Women in Microbial Physiology and Metabolism, Fronteirs in Microbiology 2024, May 21:15:1356733.  

  4. Popova L, Carr RA and Carabetta VJ. Recent contributions of proteomics to our understanding of reversible Nε-lysine acylation in bacteria. Women in Proteomics and Metabolomics special issue. Journal of Proteome Research  2024, doi.org/10.1021/acs.jproteome.3c00912.

  5. Halawa M, Akantibila M, Reid BE and Carabetta VJ. Therapeutic proteins have the potential to become new weapons in the fight against antimicrobial resistance. Frontiers in Bacteriology 2023, 2: 130444. 

  6. Copling A, Akantibila M, Kumaresan R, Fleischer G, Cortes D, Tripathi R, Carabetta VJ and Vega SL. Recent advances in antimicrobial peptide hydrogels. Int J Mol Sci, 2023 24(8): 7563.

  7. Deolankar MS, Carr R, Fliorent R, Roh S, Fraimow H, and Carabetta VJ. Evaluating the efficacy of eravacycline and omadacycline against extensively drug-resistant Acinetobacter baumannii patient isolates. Antibiotics 2022, 11(10): 1298.

  8. Betchen M, Giovinco HM, Curry M, Luu J, Fraimow H, Carabetta VJ, and Nahra, R. Evaluating the effectiveness of hospital antiseptics on multidrug-resistant Acinetobacter baumannii: Understanding the relationship between microbicide and antibiotic resistance. Antibiotics 2022, 11(5): 614.

  9. Luu J, Mott CM, Schreiber OR, Giovinco HM, Betchen M and Carabetta VJ. N-epsilon-lysine acetylation of the histone-like protein HBsu regulates the process of sporulation and affects the resistance properties of Bacillus subtilis spores. Front Microbiol 2022; 12:782815.

  10. Luu J and Carabetta VJ. The contribution of N-epsilon-lysine acetylation towards regulation of bacterial pathogenesis. mSystems, 6(4): e0042221.

  11. Carabetta VJ (2021). Addressing the possibility of a histone-like code in bacteria. J Proteome Res 2020, 20(1): 27-37.

  12. Carabetta VJ, Greco TM, Cristea IM and Dubnau D. YfmK is an N-epsilon-lysine acetyltransferase that directly acetylates the histone-like protein HBsu in Bacillus subtilis. Proc Natl Acad Sci U.S.A. 2019: 116 (9): 3752-3757. 

  13. Carabetta VJ and Cristea IM. The regulation, function and detection of protein acetylation in bacteria. J Bacteriol 2017; 199(16): e00107-17.

  14. Carabetta VJ, Greco TM, Tanner AW, Cristea IM, Dubnau D. Temporal regulation of the Bacillus subtilis acetylome and evidence for a role of MreB acetylation in cell wall growth. mSystems 2016; 1(3): pii e00005-16. 

​

For a complete list of publications: https://www.ncbi.nlm.nih.gov/myncbi/1vmaRImHSlJkL/bibliography/public/

bottom of page